European Archives - Page 856 of 1213 - European Medical Journal

An Interview with Asad Mohsin Ali from Ipsen

An interview with Asad Mohsin Ali, General Manager UK and Ireland, Ipsen, who talks about how pharmaceutical companies can add value and why market access is becoming a hot topic.

Positive Phase II Trial Results Assessing Ustekinumab for the Treatment of Systemic Lupus Erythematosus (SLE)

Lupus is a condition for which the creation of new treatment options is of paramount importance. There is as yet no cure for the disease…

Award-Winning Schoen Clinic Attends Arab Health 2019 to Showcase Brand New Harley Street Hospital

Schoen Clinic – the largest family-run hospital group in Germany – will be at Arab Health 2019 to showcase its first purpose-built hospital outside…

The European Medical Journal Presents: EMJ Diabetes 6.1

EMJ Diabetes 6.1 is now available, presenting a full review of the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD 2018)…

Review of the 54th Annual Meeting of the European Association for the Study of Diabetes 2018

Held in the beautiful and culturally rich city of Berlin, Germany, this year’s European Association for the Study of Diabetes (EASD) congress was set to…

EMJ Diabetes 6.1 2018

As always, the latest EMJ Diabetes publication features an assortment of peer-reviewed articles that are sure to fascinate every diabetologist and…

Implementation of an Aggressive Management of Insulin Therapy and Carbohydrates Intake During a Trail-Running Endurance Competition in Athletes with Type 1 Diabetes Mellitus

The idea to test the implementation of an aggressive insulin and carbohydrate intervention strategy approach to Type 1 diabetes mellitus (T1DM) athletes…

Editor's Pick: How Can We Develop More Effective Strategies for Type 2 Diabetes Mellitus Prevention? A Paradigm Shift from a Glucose-Centric to a Beta Cell-Centric Concept of Diabetes

This thought-provoking paper by Saisho provides a very accessible discussion of the shift from a glucose-centric to a beta cell-centric understanding…

Abdominal Subcutaneous Adipose Tissue Gene Expression in Relation to Tissue-Specific Insulin Resistance in Human Obesity

Obesity and being overweight are major risk factors for several diseases, including cardiovascular disease and Type 2 diabetes mellitus. Adipose tissue…

Update on the Management of Diabetic Dyslipidaemia

Diabetic dyslipidaemia is characterised by low levels of HDL-C, elevated levels of LDL-C, and a high prevalence of small dense LDL particles